Related Experiment Video
Updated: Aug 9, 2026

Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
B-type natriuretic peptide and assessment of jeopardised myocardium in acute myocardial infarction
Anne Vorlat1, Marc J Claeys, Johan M Bosmans
1Department of Cardiology, Antwerp University Hospital, Belgium. anne.vorlat@uza.be
Insights
B-type natriuretic peptide (BNP) levels do not predict myocardial damage in ST-elevation myocardial infarction (STEMI). Electrocardiogram (ECG) ST-segment analysis, however, effectively estimates jeopardized myocardium in acute STEMI patients.
Area of Science:
- Cardiology
- Biomarkers
- Acute Coronary Syndromes
Background:
- B-type natriuretic peptide (BNP) is a recognized prognostic marker in acute coronary syndromes.
- The utility of BNP in quantifying jeopardized myocardium during the acute phase of ST-elevation myocardial infarction (STEMI) remains unclear.
Purpose of the Study:
- To investigate whether BNP levels at the time of percutaneous coronary intervention correlate with the extent of jeopardized myocardium in STEMI patients.
- To compare the predictive value of BNP with electrocardiogram (ECG) findings for assessing myocardial damage.
Main Methods:
- Studied 113 patients undergoing percutaneous coronary intervention for acute STEMI.
- Correlated plasma BNP levels, measured during intervention, with myocardial jeopardy assessed by coronary angiography (vascular score).
- Evaluated ECG parameters, including ST-segment elevation and depression, to assess epicardial injury extent.
Main Results:
- No significant correlation was found between BNP levels and the vascular score (r=0.026, p=0.8).
- The primary determinant of BNP levels was the time delay from symptom onset to sample collection.
- The extent of ST-segment elevation on ECG independently predicted the vascular score.
Conclusions:
- BNP measurements at initial STEMI presentation are not reliable predictors of the amount of jeopardized myocardium.
- ST-segment analysis on ECG, particularly the degree of ST-segment elevation, offers valuable insights into the extent of myocardial injury.
Background:
B-type natriuretic peptide (BNP) is used as prognostic marker in acute coronary syndromes. It is unknown whether BNP reflects the amount of jeopardised myocardium in the initial phase of acute ST-elevation myocardial infarction (STEMI).
Methods:
Patients admitted for percutaneous coronary intervention in the acute phase of STEMI were studied. Samples for BNP were taken at the time of coronary intervention and were correlated with the amount of jeopardised myocardium. This was defined on coronary angiography as the vascular region distal to the infarct-related lesion and was expressed by a vascular score. The extend of epicardial injury on ECG was evaluated by: summation of ST-segment elevation in the infarct-related leads, number of leads with > or = 1 mm ST-segment elevation and number of leads with > or = 1 mm ST-segment depression/elevation.
Results:
A total of 113 patients (median age (25th, 75th percentile) 61 (54, 69)) were studied. Median BNP was 27 pg/ml (12, 62) and was assessed 225 min (150, 315) after onset of pain. There was no significant relation between BNP and vascular score (r=0.026, p=0.8). The only independent variable of BNP was time delay between onset of pain and sample collection. Stepwise regression identified the extent of ST-segment elevation as independent predictor of the vascular score.
Conclusion:
At initial presentation of STEMI, BNP measurement does not allow a correct prediction of jeopardised myocardium. In contrast, ST-segment analysis, in particularly the extent of ST-segment elevation, provides useful information about the extent of jeopardised myocardium.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis IV: Nursing Management
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Myocarditis III: Medical Management
Acute Coronary Syndrome III: Diagnostic Studies

